548 related articles for article (PubMed ID: 18035865)
1. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
Hermansen K; Mortensen LS
Drug Saf; 2007; 30(12):1127-42. PubMed ID: 18035865
[TBL] [Abstract][Full Text] [Related]
2. Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
Purnell JQ; Weyer C
Treat Endocrinol; 2003; 2(1):33-47. PubMed ID: 15871553
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological management of type 2 diabetes mellitus: an update.
El-Kaissi S; Sherbeeni S
Curr Diabetes Rev; 2011 Nov; 7(6):392-405. PubMed ID: 21846326
[TBL] [Abstract][Full Text] [Related]
5. A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies.
Barnett A; Allsworth J; Jameson K; Mann R
Curr Med Res Opin; 2007 Jul; 23(7):1493-507. PubMed ID: 17559747
[TBL] [Abstract][Full Text] [Related]
6. [Limitations of insulin-dependent drugs in the treatment of type 2 diabetes mellitus].
ValerĂ³n PF; de Pablos-Velasco PL
Med Clin (Barc); 2013 Sep; 141 Suppl 2():20-5. PubMed ID: 24444520
[TBL] [Abstract][Full Text] [Related]
7. Oral antidiabetic agents in type 2 diabetes.
Levetan C
Curr Med Res Opin; 2007 Apr; 23(4):945-52. PubMed ID: 17407651
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Pediatric Type 2 Diabetes.
Smith JD; Mills E; Carlisle SE
Ann Pharmacother; 2016 Sep; 50(9):768-77. PubMed ID: 27307414
[TBL] [Abstract][Full Text] [Related]
9. The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
Munir KM; Davis SN
Expert Opin Pharmacother; 2015; 16(15):2331-41. PubMed ID: 26340427
[TBL] [Abstract][Full Text] [Related]
10. Body Weight Considerations in the Management of Type 2 Diabetes.
Apovian CM; Okemah J; O'Neil PM
Adv Ther; 2019 Jan; 36(1):44-58. PubMed ID: 30465123
[TBL] [Abstract][Full Text] [Related]
11. New drugs for type 2 diabetes mellitus: what is their place in therapy?
Krentz AJ; Patel MB; Bailey CJ
Drugs; 2008; 68(15):2131-62. PubMed ID: 18840004
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
Tahrani AA; Barnett AH; Bailey CJ
Nat Rev Endocrinol; 2016 Oct; 12(10):566-92. PubMed ID: 27339889
[TBL] [Abstract][Full Text] [Related]
13. Diabetes medications and body weight.
Mitri J; Hamdy O
Expert Opin Drug Saf; 2009 Sep; 8(5):573-84. PubMed ID: 19538102
[TBL] [Abstract][Full Text] [Related]
14. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
Kumar A
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
[TBL] [Abstract][Full Text] [Related]
15. What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?
Zenari L; Marangoni A
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():17-25. PubMed ID: 24034516
[TBL] [Abstract][Full Text] [Related]
16. Complementing insulin therapy to achieve glycemic control.
Barnett AH
Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
[TBL] [Abstract][Full Text] [Related]
17. Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Frandsen CS; Dejgaard TF; Madsbad S
Lancet Diabetes Endocrinol; 2016 Sep; 4(9):766-780. PubMed ID: 26969516
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
[TBL] [Abstract][Full Text] [Related]
19. New treatments for patients with type 2 diabetes mellitus.
Wolffenbuttel BH; Graal MB
Postgrad Med J; 1996 Nov; 72(853):657-62. PubMed ID: 8944206
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of the older patient with type 2 diabetes mellitus.
Neumiller JJ; Setter SM
Am J Geriatr Pharmacother; 2009 Dec; 7(6):324-42. PubMed ID: 20129254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]